Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06676059 · ClinicalTrials.gov registry record
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
A clinical trial of Alcoholism and Substance-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT06676059 is a study of Alcoholism and Substance-Related Disorders that is actively recruiting participants, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 10,000 participants, above the 221-participant average among 65 other Alcoholism trials with a reported enrollment target (4425% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06676059, a study of Alcoholism and Substance-Related Disorders, is actively recruiting participants, sponsored by National Institute on Drug Abuse (NIDA).
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: About 1.5 million adults in the US enter alcohol or substance use treatment programs each year. Unfortunately, more than half of patients do not finish their program. For those who start treatment, about 70% return to substance use within weeks or months after starting treatment. To discover why patients drop out of treatment and return to substance use - and what can be done about it - researchers need to learn more about people who use drugs and alcohol. Objective: To create a data repository by gathering survey and smartphone data from adults who use drugs and alcohol in order to conduct future research. Eligibility: Adults who have used drugs or alcohol in the past and have a Android smartphone. The researchers will recruit targeted demographics at different times throughout the duration of the study period. Design: Data will be collected for up to 6 months. All research activities will be online. Participants will download a smartphone app called TTRU-Curtis AWARE and keep it active on their phone. The app will run in the background and collect participant data, including: screen unlocks, duration of time the screen is on; apps used; words typed (except passwords); duration and time of phone calls; estimated location (exact location is not collected); and movement, such as how many steps are taken in a day. All personally identifying information is automatically removed before the data is stored (including phone numbers, names, or locations described in messages). Each day, participants will receive a text with a link to a survey. They will answer questions about their mood, behavior, and substance use from the day before. This survey should take less than 5 minutes to complete. Every 30 days, participants will complete a longer survey. They will answer questions about their personal relationships, risky behaviors, mood, substance use, and feelings. They can skip any questions they do not feel comfortable answering. These surveys should ta
Conditions Studied
Study Locations (1)
Maryland
- National Institute on Drug Abuse - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2026-03-26 |
| Est. Completion | 2044-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06676059
The ClinicalTrials.gov registry entry for NCT06676059 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 221-participant average among 65 other Alcoholism trials with a reported enrollment target (4425% higher). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcoholism appearing as the primary indexed condition, and to 0 interventions.
NCT06676059 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT06676059 about?
NCT06676059 is a clinical study titled "SMART-r: Substance Monitoring and Active Relapse Tracking Repository". Background: About 1.5 million adults in the US enter alcohol or substance use treatment programs each year. Unfortunately, more than half of patients do not finish their program. For those who start treatment, about 70% return to substance use within weeks or months after starting treatment. To dis...
What is the current status of trial NCT06676059?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2026-03-26. Estimated completion is 2044-12-31.
What conditions does trial NCT06676059 study?
This clinical trial studies the following conditions: Alcoholism, Substance-Related Disorders.
Who is sponsoring clinical trial NCT06676059?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06676059 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Naltrexone in AUD Reward Drinkers
RECRUITING · Phase 4
-
Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
RECRUITING
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study
RECRUITING
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
-
CRP and S&A for Inpatient Veterans
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.